Help us: Donate
Follow us on:
×

Tag: Aubrey de Grey

Aubrey de Grey
We recently caught up with Dr. Aubrey de Grey and talked to him about the upcoming Dublin Longevity Summit and how things are looking on the advocacy landscape. Hi Aubrey, great to see that you are the co-organizer and a keynote speaker at the Longevity Summit Dublin 2022, an all-new conference happening on September 18th...
Aubrey de Grey EARD2021
At our fourth annual Ending Age-Related Diseases conference, Dr. Aubrey de Grey discusses the transition of rejuvenation biotechnology from proof-of-concept to companies engaging in clinical trials, and he outlines the challenges inherent in such a move. Script It's great to be here, of course. I just thought I'd start by saying that some of you...
Looking forward
We recently caught up with Dr. Aubrey de Grey and Michael Rae from SENS Research Foundation (SRF) about the landscape in the field. We asked them two simple questions, and they joined forces to give us their combined insights. Lifespan.io: First, do you think we can defeat aging? Of course I think we can defeat...
Crypto is an important source of support for longevity tech.
VitaDAO, the world’s first decentralized intellectual property collective, hosted a discussion and AMA on Youtube yesterday. The event featured guests Dr. Aubrey de Grey from SENS Research Foundation and Vitalik Buterin, one of the co-founders of Ethereum. Introducing Aubrey de Grey and Vitalik Buterin Dr. Aubrey de Grey is a British biomedical gerontologist who researched...
SenNet
The National Institute of Health is going all-in on cellular senescence with its recently announced SenNet program. We asked two of the leading experts in aging research to weigh in on this initiative. The NIH takes notice  Cellular senescence has been at the forefront of longevity researchers' minds for quite some time now, as it...
Longevity Therapeutics banner
We continue our coverage of Longevity Therapeutics 2021 and bring you part 2 of day 1. Read the first article of the series here. Dr. Steven Braithwhite - Chief Scientific Officer, Alkahest Steven Braithwhite from Alkahest gave an update on the company’s ongoing clinical trials. Alkahest has been sifting plasma proteome in search for proteins...

Want the latest longevity news? Subscribe to our Newsletter!